Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Alzheimer’s Therapy May Come From New Look at Old Drugs
Bloomberg
Friday, April 11, 2014 - 3:35pm
tags:
Pfizer, Sanofi, Alzheimer's disease
Earnings Preview: Johnson & Johnson Q1 2014
Seeking Alpha
Friday, April 11, 2014 - 3:10pm
tags:
earnings, JNJ
Second drug spending report predicts double-digit increases coming
Fierce Pharma
Friday, April 11, 2014 - 11:42am
tags:
drug spending
Natco looking to block Indian patent for Gilead's Sovaldi
Fierce Pharma
Friday, April 11, 2014 - 11:41am
tags:
India, Natco, Gilead Sciences, Sovaldi, hepatitis C
Plandai Biotechnology's Cannabis Extracts Could Further Shape Marijuana Debate
Yahoo
Friday, April 11, 2014 - 11:40am
tags:
Medical Marijuana, Plandai Biotechnology
The Stalled State Of MannKind
Seeking Alpha
Friday, April 11, 2014 - 11:38am
tags:
MannKind, diabetes, Afrezza
Hamburg to PhRMA: If you don't have quality, the rest doesn't matter
Fierce Pharma
Friday, April 11, 2014 - 10:35am
tags:
PhRMA, Margaret Hamburg, FDA
The CEO Is In: Pharma Exec Started as Physician
WSJ Online
Friday, April 11, 2014 - 10:26am
tags:
physicians, Merck Serono, Pharma CEOs
Doctors welcome hepatitis C drug rivals, Gilead still leads
Yahoo/Reuters
Friday, April 11, 2014 - 8:47am
tags:
physicians, hepatitis C, Gilead Sciences, Sovaldi, Merck, AbbVie, Bristol-Myers Squibb
IPO Preview: Phibro Animal Health
Seeking Alpha
Friday, April 11, 2014 - 8:45am
tags:
IPOs, Phibro Animal Health, animal health
IPO Preview: Aldeyra Therapeutics
Seeking Alpha
Friday, April 11, 2014 - 8:44am
tags:
IPOs, Aldeyra Therapeutics
Roche's Competitive Advantage
Seeking Alpha
Friday, April 11, 2014 - 8:43am
tags:
Roche, JNJ, Merck, Pfizer
Biotech: Like Lambs to the Slaughter
Barron's
Thursday, April 10, 2014 - 11:16pm
tags:
biotech
2 Biotech Stocks to Watch: Merrimack Pharmaceuticals and Sunesis Pharmaceuticals
Motley Fool
Thursday, April 10, 2014 - 11:13pm
tags:
Merrimack Pharmaceuticals, Sunesis, pancreatic cancer, MM-398, vosaroxin
Gilead Sciences: How Big a Threat is Merck?
Barron's
Thursday, April 10, 2014 - 10:52am
tags:
Gilead Sciences, Merck, hepatitis C, MK-5172, MK-8742, Sovaldi
Roche says did not collude with Novartis to restrict competition
Reuters
Thursday, April 10, 2014 - 10:46am
tags:
Roche, Novartis, collusion
Boston Scientific eyes Israel in global marketing push
Fierce Medical Devices
Thursday, April 10, 2014 - 10:44am
tags:
devices, Boston Scientific, Israel, emerging markets
Tendyne raises $25M in Series C financing for mitral valve device
Fierce Medical Devices
Thursday, April 10, 2014 - 10:43am
tags:
devices, mitral valve, Tendyne
Celladon's Mydicar candidate granted breakthrough therapy designation by FDA
The Fly on the Wall
Thursday, April 10, 2014 - 10:39am
tags:
Celladon, Mydicar, breakthrough therapies, FDA, heart failure
3 Breast Cancer Drugs With Big Potential
Motley Fool
Thursday, April 10, 2014 - 10:37am
tags:
breast cancer, Pfizer, Novartis, Eli Lilly, LEE011, LY2835219, palbociclib, CDK 4/6 inhibitors

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.